Tablets India Limited - capsule - 30 - 30 Capsules
₹424
OTCIn stock
Hapenz Syrup
Tablets India Limited - syrup - 1 - 175 Ml
₹178
Rx requiredIn stock
AMBROLITE S-SF
Tablets India Limited - unspecified - NA - 100ML
₹120
Rx requiredIn stock
Bifilac Dry Syrup
Tablets India Limited - syrup - 1 - 50 Ml
₹134
Rx requiredIn stock
Ambrolite 2S Expectorant
Tablets India Limited - syrup - 1 - 100 Ml
₹125
Rx requiredIn stock
Ambrolite Syrup (100 Ml)
Tablets India Limited - syrup - 1 - 100 Ml
₹38
Rx requiredIn stock
Bifilac Capsule
Tablets India Limited - capsule - 10 - 10 Capsules
₹141
Rx requiredIn stock
Ambrolite Cold Syrup
Tablets India Limited - syrup - 1 - 30 Ml
₹91
Rx requiredIn stock
Medicine FAQs
What is Ambrolite S Syrup used for?
Ambrolite S Syrup is a medicine available on PingMeDoc Pharmacy. Consult your doctor for the specific indication that applies to you — this page is for educational purposes only.
Is Ambrolite S Syrup a prescription medicine?
Yes. Ambrolite S Syrup is a prescription-only (Rx) medicine. Upload a valid prescription from a registered medical practitioner during checkout. We cannot dispense it without a valid Rx.
How much does Ambrolite S Syrup cost on PingMeDoc Pharmacy?
Ambrolite S Syrup starts at ₹131 on PingMeDoc Pharmacy. Available in syrup 1 100 Ml. Final price is confirmed at checkout and may vary by variant and location.
Who manufactures Ambrolite S Syrup?
Ambrolite S Syrup is manufactured by Tablets India Limited. PingMeDoc Pharmacy sources medicines only from licensed manufacturers and distributors.
How is Ambrolite S Syrup delivered?
Ambrolite S Syrup is delivered across India via our licensed pharmacy partners. Standard delivery timelines are confirmed at checkout. Chennai customers can opt for chargeable same-city express delivery.
Product information is for general awareness and does not replace professional medical advice. Always follow a clinician's guidance and upload a valid prescription when required.
Pharmacy categories
Browse by category — pain relief, diabetes care, baby care, and more.